Organ in Biological Technology

Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus

... the SELENA SLEDAI flare index and by BILAG A or B organ domain scores decreased over four years of ... of adverse events (in general and by system organ class), serious adverse events, infections, ... of patients experiencing one new BILAG A organ domain score (which would indicate a severe flare ...

Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

... mycophenolate mofetil (MMF) for the prevention of organ rejection in kidney transplant recipients. ... transplants. According to United Network for organ Sharing (UNOS), in 2007, 79.3% of kidney ... injection) is indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver, ...

Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug

... for prophylaxis of acute rejection of solid organ transplantation. TOL101 is a biologic protein ... and ultimate failure, of transplanted organs. organ transplantation is often the only viable treatment for many end-stage organ diseases. "We are extremely pleased with ...

GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery

... United States for use in surgery to treat pelvic organ prolapse. GYNECARE PROLIFT+M(TM) includes a ... stabilization of fascial structures (fibrous organ connective tissues) of the pelvic floor in ... with the GYNECARE PROLIFT+M(TM) System for pelvic organ prolapse. With GYNECARE PROLIFT+M(TM), surgeons ...

CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone

... January 14, 2009 came from a Kansas-based organ and tissue procurement organization. Since ... of donor families and with the support of the organ and tissue procurement organizations, CryoLife ... are grateful to the many people who register as organ and tissue donors. Their kindness is ...

Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics

... computer systems, today announces that Allen organ Company recently received a Catalyst Module ... ) Allen organ Company, the world's largest manufacturer of ... John Adamson, Chief Engineer for the Allen organ Company. "I'm looking forward to examining the ...

Study Shows Machine Perfusion Significantly Improves Transplant Results

... the temperature and vascular performance of the organ in real time, while preserving it by pumping the ... continuously with a cold solution, even while the organ is being transported to its intended recipient. ... said David Kravitz, Chief Executive Officer of organ Recovery Systems, the manufacturer of LifePort. ...

Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice

... International Foundation (the international organ exchange organisation for Austria, Belgium, ... Eurotransplant area. The manufacturers, organ Recovery Systems of Chicago, USA provided the ... the preservation and transport of kidneys from organ recovery until transplantation. ...

AlloSource, Tissue Recipient Join 'Stars of Life' Affected by Organ and Tissue Donation Aboard Donate Life Float in 2009 Rose Parade(R)

... which honor those who've made a lasting impact on organ and tissue donation. He was selected for his ... AlloSource in this grand tradition honoring organ and tissue donation," said Thomas Cycyota, ... partners and the country's most reputable organ procurement organizations. AlloSource is ...

Don't Wait - Do It Now!(TM) Become an Organ and Tissue Donor

... Ohio, Nov. 25 /PRNewswire/ -- The need for organ and tissue donation increases daily. In Ohio, nearly 3,000 people are waiting for a life saving organ transplant and many more are in need of tissue. ... the opportunity to save a life by becoming an organ and tissue donor. Efforts from last ...

Tengion Announces Second Closing of Series C Financing

... to meet the critical need of patients with organ failure," said Steven Nichtberger , M.D., ... addressing the most critical issues facing organ failure patients. With late stage products in ... neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses ...

Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association

... NVCA invited Tengion to showcase its Autologous organ Regeneration Platform(TM) for nearly ... neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses ... address the most critical problems facing organ and tissue failure patients, enabling people to ...

Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation

... pipeline, and continue to validate our Autologous organ Regeneration Platform(TM)." About Tengion ... neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses ... address the most critical problems facing organ and tissue failure patients, enabling people to ...

AST Endorses Istanbul Declaration to End Organ Trafficking and Transplant Tourism

... representative. The Declaration aims to combat organ commercialism and to preserve the protection and safety of living organ donors. The message underlying the creation of ... countries to implement programs that will prevent organ failure and to meet the organ needs of its ...

Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection

... of the transplant recipient and patient risk for organ rejection and/or infection. These data ... corticosteroids to lower the potential risk of organ rejection. In follow-up analysis of the ... et al. were able to document five biopsy-proven organ rejections in patients with stronger immune ...

Tengion Announces European Orphan Drug Designation for Neo-Bladder Augment

... neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses ... (autologous) cells to create a functional neo- organ or neo-tissue that is designed to harness an individual's ability to regenerate specific organ tissue, catalyzing the body's innate ability to ...

LifeNet Health Saves 303 Lives and Restores Health to 265,967 Patients in 2007

... with approximately 80 hospitals, including five organ transplant centers in its service area, to ... Center. These four hospitals saw a total of 66 organ donors. Hospital development efforts by LifeNet ... die each week waiting for a life-saving organ transplant that doesn't come in time. Virginians ...

Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding

... and finalised the acquisition of its ToleroTrans organ anti-rejection technology. Following this ... patients and thereby reduce the risk of organ rejection. About Circassia Circassia is a ... The company is also developing its ToleroTrans organ anti-rejection technology, which uses a similar ...

JCI table of contents: Dec. 3, 2007

... of small vessels feeding the transplanted organ is likely to play a key role in preventing ... of oxygen (hypoxia) are almost always harmful to organ tissues, researchers examined the functionality ... transplantation might be the key to preventing organ rejection and fibrosis. In an accompanying ...

LifeNet Health and LOPA Announce a Partnership

... announces a strategic affiliation with Louisiana organ Procurement Agency (LOPA), a federally designated organ procurement organization. The LifeNet Health - ... medical community and the general public about organ and tissue donation, working with families ...

Web Portal Makes Organ Donation Easy

... Pa., Aug. 20 /PRNewswire/ -- Statewide organ donation groups today formally unveiled a Web portal that will enable individuals to sign up as organ donors online - rather than waiting until their ... Vehicle Services Web site, where they can add the organ donor designation using the online service. The ...

Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial

... added to conventional therapy, significantly improved hemodynamics and organ dysfunction and reduced 28-day mortality in patients with severe sepsis ... (inotropic score, 28.6 to 22.4; P = 0.14). - Sequential organ Failure Assessment scores improved in the Toraymyxin (TM) group ...

Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue

... with the support of Methuselah Foundation, is applying its breakthrough organ printing technologies to make that prediction a reality. ... is a seed-stage regenerative medicine company that applies proprietary organ printing technology to solve critical problems in transplant medicine, ...

American Transplant Congress 2009

... Ethics, Economics & Regulatory Issues Incentives for organ Donation New UNOS Pediatric Donor Allocation Policies Tissue Engineering organ Allocation Worldwide Transplantation Controversies ...

The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment

... the potential to move into the lungs and block circulation to this vital organ creating a life-threatening condition - pulmonary embolism, or PE - which ... the potential to move into the lungs and block circulation to this vital organ creating a life-threatening condition - pulmonary embolism, or PE - which ...

AlloSource Distributes Record Amount of Tissue in 2008

... Establishment. Reinvesting close to 45 percent of revenues with organ Procurement Organization recovery agencies. These funds were used for a ... its growing network of surgeons, partners and the country's most reputable organ procurement organizations. AlloSource is accredited by the American ...

Tengion to Present at the Piper Jaffray 20th Annual Healthcare Conference

... and commercializing human neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses biocompatible materials and a ... candidates may ultimately address the most critical problems facing organ and tissue failure patients, enabling people to lead healthier lives ...

Alexion Reports Third Quarter 2008 Results

... a disorder in which uncontrollable blood clotting often leads to multiple organ failure; and cold hemagglutinin disease ("CAD"), an auto-immune hemolytic ... of kidney transplant patients who are known to have a higher risk of organ rejection. Oncology Program Alexion is developing its novel, ...

Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System

... is considered to be particularly important for preserving tissue and organ function under conditions of acute ischemia, which result from reduced ... structure and preventing or reducing injuries at the cellular, tissue and organ level. Two international clinical trials on hypothermia after cardiac ...

Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning

... and commercializing human neo-organs and neo-tissues using our Autologous organ Regeneration Platform(TM). Tengion uses biocompatible materials and a ... candidates may ultimately address the most critical problems facing organ and tissue failure patients, enabling people to lead healthier lives ...

Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma

... were treated with escalating doses of RIT based on patient-specific organ dosimetry. Of the 18 patients treated with RIT as single-agent salvage ... regardless of RIT dose. The investigators concluded that patient-specific, organ dosimetry-based significant dose escalation with RIT was achieved with ...

Tengion Appoints Jeff Randall to Board of Directors

... a clinical stage biotechnology company, has pioneered the Autologous organ Regeneration Platform(TM) that catalyzes the body's innate ability to ... product candidates have the potential to cure - rather than treat - organ and tissue failure, enabling people to lead healthier lives without donor ...

Tengion to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

... a clinical stage biotechnology company, has pioneered the Autologous organ Regeneration Platform(TM) that catalyzes the body's innate ability to ... product candidates have the potential to cure -- rather than treat -- organ and tissue failure, enabling people to lead healthier lives without donor ...

Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community

... programs in oncology, diabetes, cardiovascular disease and solid organ transplant rejection, including: -- developmental diabetes compounds ... blocker under development to replace cornerstone therapy in solid organ transplantation, which the company expects to submit to the FDA for ...

Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan

... to low levels of CO, can cause death or permanent brain, heart, or organ damage.(4,5) Certain home CO detectors don't alarm when low levels of CO ... of CO-poisoning and countless others suffer permanent brain, heart and organ damage. All too often CO-poisoning goes undiagnosed, silently robbing ...

Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington

... and thereby markedly increase opportunities for healing and restoring organ function. The company's first product in development, CCG-TH30, is ... medicine, namely, the ability to target and then keep cells in an organ of interest, in this case, the heart. The issuance of a patent for this ...

Blood Donations in U.S. Testing Positive for Chagas' Disease

... is usually mild and unrecognized, but persists lifelong and may lead to organ damage, particularly of the heart and esophagus, causing an estimated ... also can be severe in people whose immune systems are suppressed, such as organ transplant recipients. According to the CDC, as many as 8 to 11 million ...

Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program

... of ITNS. "We are excited to be able to develop materials that empower organ transplant recipients and their caregivers to take a more active role in ... the education and clinical practice excellence of nurses caring for solid organ transplant patients. Today, ITNS is a leading transplant organization with ...

The Law Offices of Brian D. Witzer Wins 6+ Million Dollar Verdict

... Epidermal Necrolysis (TEN) are serious life-threatening disorders which affect the skin and mucous membranes, which can also result in blindness, organ failure and death. Symptoms begin with flu-like symptoms followed by a painful red or purplish rash that spreads and blisters, eventually causing the ...

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

... syndrome, bronchiolitis obliterans (BO), immune cytopenias and chronic immunodeficiency. The manifestations of cGVHD may be restricted to a single organ or tissue or may be widespread. Chronic GVHD can lead to debilitating consequences, e.g., joint contractures, loss of sight, end-stage lung disease, ...